Bioworld Financial Watch articles from February 2003

Bioworld Financial Watch archives from February 2003

As war looms, sector could have 'biggest product year ever'.
February 3, 2003... With 20 drugs approved last year, a somewhat brightened market picture in the final quarter of 2002 and Phase Ill data due in the months ahead, analysts are finding cause for optimism even as the rumblings of war grow louder. The efforts...

Money Raised by Biotech in 2003 Vs. 2002.
February 3, 2003... Money Raised By Biotech In 2003 Vs. 2002 Millions Jan. 1-Jan. 30, Jan. 1-Jan. 31, 2003: $579.57M 2002: $599.553M Public/Other * 77 334...

10 Biggest U.S. Gainers & Losers for the Week.
February 3, 2003... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Alliance 107.14 Affymetrix 4.84 Miravant 48.19 Biogen 2.73 Photogen 33.33 OraSure Tech 1.94 OraSure Tech...

U.S. Public Offering Performance by Underwriter: Jan. 1 - Dec. 31, 2002.
February 3, 2003... U.S. Public Offering Performance By Underwriter: Jan. 1 - Dec. 31, 2002 * UNDERWRITERS' PERFORMANCE ON ALL PUBLIC OFFERINGS JAN. 1 - DEC. 31, 2002: FULL CREDIT TO ALL UNDERWRITERS, RANKED BY GROSS PROCEEDS * Underwriter ...

BioWorld Stock Report for Public Biotechnology Companies.
February 3, 2003... BioWorld Stock Report For Public Biotechnology Companies Close Close % Change Company Symbol 1/24 1/31 WK YTD 3D Pharma DDDP 5.64 ...

Industry mourns shuttle loss; work to continue another time.
February 10, 2003... As investigators continue to sift through pieces of the disintegrated Space Shuttle Columbia and the nation mourns the deaths of seven astronauts, scientists involved in about 80 experiments aboard the doomed craft also are mourning the loss of...

Money Raised By Biotech In 2003 Vs. 2002.
February 10, 2003... Money Raised By Biotech In 2003 Vs. 2002 Millions Jan. 1 - Feb. 6, Jan. 1 - Feb. 7, 2003: $667.51M 2002: $873.803M Public/Other * 104 336 Private Biotechs ...

10 Biggest U.S. Gainers & Lossers for the Week.
February 10, 2003... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) By (Dollars) eXegenics 74.36 Scios 9.40 Photogen 61.25 Digene 3.82 Valentis 43.94 Cephalon 3.54 Cygnus ...

Public Financing Of Biotechnology: January 2003.
February 10, 2003... Public Financing Of Biotechnology: January 2003 I. COMMENCED TRADING IN JANUARY INITIAL OFFERINGS Company Date Date Shares/ Price (Symbol) # Filed Comm. ...

Other Financings Of Public Biotechnology Companies: January 2003.
February 10, 2003... Other Financing of Public Biotechnology Companies: January 2003 TOTAL: $104.308M Company Type of Number of Shares, (Symbol) # Financing Units Or Warrants ...

Venture Capital And Corporate Investents In Biotechnology Companies: January 2003.
February 10, 2003... Venture Capital And Corporate Investents In Biotechnology Copanies: January 2003 I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $277.74M Company Location Date Aton Pharma Inc. ...

Money Raised By Biotech in 2003: January.
February 10, 2003... Money Raised By Biotech in 2003: January Type of financing 1 ($M) Total ($M) Public offerings 254.2 254.2 Private biotechs 277.7 277.7 Public/other 104.3 104.3 Milestones/equity 34.0 34.0 Total...

BioWorld Stock Report For Public Biotechnology Companies.
February 10, 2003... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change 1/31 2/7 WK YTD 3D Pharma DDDP 5.65 5.67 ...

London Stock Exchange.
February 10, 2003... LONDON STOCK EXCHANGE Company Symbol 1/31 2/7 %WK %YTD Volume Acambis ACM 207.5 228.5 10.12 -17.51 3496 Antisoma ASM 26.25 26.5 0.95 -7.83 5197 British Biotech ...

Toronto Stock Exchange.
February 10, 2003... TORONTO STOCK EXCHANGE Company Symbol 1/31 2/7 %WK %YTD Volume Adherex AHX 0.325 0.335 3.08 -22.09 71 Angiotech Pharma ANP 55.55 54.7 -1.53 2.11 78 Anormed ...

BioPartnering North America: getting the ear of gatekeepers.
February 17, 2003... The necessary relationship between biotechnology companies and big pharma drives both industries -- pharma has the money but often has science needs; biotechnology has the science but often lacks financial resources. In the depressed...

Money Raised By Biotech In 2003 Vs. 2002.
February 17, 2003... Money Raised By Biotech In 2003 Vs. 2002 Jan. 1 - February 13, Jan. 1 - February 14, 2003; $772.76M 2002; $1,094M Public/Other * 169 356 Private...

10 Biggest U.S. Gainers & Losers for the Week.
February 17, 2003... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Immtech 68.12 BioReliance 2.43 Avanir 53.25 Neurocrine Biasci 2.33 Cell Pathways 52.94 NPS Pharma 1.72...

Clinical Trial Update: January 2003.
February 17, 2003... Clinical Trial Update: January 2003 Company * Product Description (Country; Symbol) AUTOIMMUNE Alexion Eculiazumab A humanized monoclonal Pharmaceuticals ...

Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations and Approvals: January 2003.
February 17, 2003... Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: January 2003 Company Product Description (Country; Symbol) AUTOIMMUNE GeneLabs Anastar Prasterone, GL701;...

FDA Submissions, Approvals and Other Actions: January 2003.
February 17, 2003... FDA Submissions, Approvals And Other Actions: January 2003 Company * Product (Country; Symbol) AUTOIMMUNE Amgen Inc. Enbrel (AMGN) (FDA-approved)...

BioWorld Stock Report for Public Biotechnology Companies.
February 17, 2003... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close % Change 2/7 2/14 WK YTD 3D Pharma DDDP 5.67 5.67 ...

London Stock Exchange.
February 17, 2003... LONDON STOCK EXCHANGE Company Symbol 2/7 2/14 %WK %YTD Volume Acambis ACM 228.5 223.5 -2.19 -19.31 1750 Antisoma ASM 26.5 26.5 0.00 -7.83 1069 British Biotech ...

Toronto Stock Exchange.
February 17, 2003... TORONTO STOCK EXCHANGE Company Symbol 2/7 2/14 %WK %YTD Volume Adherex AHX 0.335 0.33 -1.49 -23.26 12 Angiotech Pharma ANP 54.7 54.47 -0.42 1.68 136 Anormed ...

RNAi research draws attention of investors, established firms.
February 24, 2003... Like making good soup, bringing laboratory discoveries to the point where they are useful to biotechnology typically takes a long time -- and the science of RNA interference, or RNAi, is just about ready to dish up. Ribozyme...

Money Raised By Biotech In 2003 Vs. 2002.
February 24, 2003... Money Raised By Biotech In 2003 Vs. 2002 Jan. 1 - Feb. 20, 2003: Jan. 1 - Feb. 21, 2002: $876.06M $1,441.03M Public/Other * 213 426 Private...

10 Biggest U.S. Gainers for the Week.
February 24, 2003... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Demegen 75.00 ImClone Sys 2.76 Ostex Int'l 43.36 Trimeris 2.42 Praecis 28.79 IGEN 2.42...

Biotechnology Company Deals With Other Biotechnology Companies: Collaborations, Agreements, Equity Participation, Dec. 24, 2002 - Feb.
February 24, 2003... Biotechnology Company Deals With Other Biotechnology Companies: Collaborations, Agreements, Equity Participation, Dec. 24, 2002 - Feb. 19, 2003 # Company * Company * Type/Product Area (Country; (Country;...

Biotechnology Company Deals With Miscellaneous Companies: Collaborations, Agreements, Equity Participation, Dec. 24, 2002 -- Feb. 19, 2003.
February 24, 2003... Biotechnology Company Deals With Miscellaneous Companies: Collaborations, Agreements, Equity Participation, Dec. 24, 2002 -- Feb. 19, 2003 # Company * Company * (Country; Symbol) Accelrys Inc. IBM Corp. and...

Manufacturing, Marketing and Distribution Agreements Between Biotech Companies: Dec. 24, 2002 - Feb. 19, 2003.
February 24, 2003... Manufacturing, Marketing And Distribution Agreements Between Biotech Companies: Dec. 24, 2002 - Feb. 19, 2003 # Company * Company * Product (Country; (Country; Symbol) Symbol) ...

Biotech - Biotech Collaborations: Modified And Terminated Agreements, Dec. 24, 2002 - Feb. 19, 2003.
February 24, 2003... Biotech - Biotech Collaborations: Modified And Terminated Agreements, Dec. 24, 2002 - Feb. 19, 2003 # I. MODIFIED AGREEMENTS Company * Company * Change from original (Country; (Country; ...

BioWorld Stock Report For Public Biotechnology Companies.
February 24, 2003... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change Vol 2/14 2/21 WK YTD (000) 3D Pharma DDDP 5.67...